FDA Revokes Approval for Sun Pharma's Seizure Drug Over Compliance Issues

The U.S. Food and Drug Administration has revoked an approval issued in March to India's Sun Pharma Advanced Research Company Ltd (SPARC) to launch a drug for seizures, citing manufacturing quality problems at its production site.